How conducting a clinical trial affects physicians' guideline adherence and drug preferences.
about
Study of neurontin: titrate to effect, profile of safety (STEPS) trial: a narrative account of a gabapentin seeding trialWorld health dilemmas: Orphan and rare diseases, orphan drugs and orphan patientsThe impact of the process of clinical research on health service outcomesInformation from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic reviewPrescription pattern and its influencing factors in Chinese county hospitals: a retrospective cross-sectional studyMore regulation of industry-supported biomedical research: are we asking the right questions?Those who have the gold make the evidence: how the pharmaceutical industry biases the outcomes of clinical trials of medications.Effects on patients of their healthcare practitioner's or institution's participation in clinical trials: a systematic reviewDoes family medicine have a professional obligation to play a leading role in pharmaceutical industry-sponsored drug research?: no.Promotional methods used by representatives of drug companies: a prospective survey in general practice.A Cross-sectional Study Assessing Predictors of Essential Medicines Prescribing Behavior Based on Information-motivation-behavioral Skills Model among County Hospitals in Anhui, China.New developments and controversies in iron metabolism and iron chelation therapy.Clinical drug trials in general practice: a 10-year overview of protocols.How may clinical research improve healthcare outcomes?Odense Pharmacoepidemiological Database: A Review of Use and Content.Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromesDoes participation in clinical trials influence the costs of future management of patients?Participation in a clinical trial influences the future management of patients with gastro-oesophageal reflux disease in general practice.La médecine familiale a-t-elle une obligation professionnelle de jouer un rôle prépondérant dans la recherche sur les médicaments financée par l’industrie pharmaceutique?: NON.Physician-industry collaboration: conflicts of interest and the imputation of motive.Pharmaceutical companies and healthcare providers: Going beyond the gift - An explorative review.Study on essential drug use status and its influencing factors among cerebral infarction inpatients in county level hospitals of Anhui Province, China.The benefits and savings from publicly funded clinical trials of prescription drugs.
P2860
Q24604806-C40B690A-A81D-4DBF-AC7B-3D155BF28749Q26826936-FE26FD31-F904-4D1C-B3D5-A8D4B973C0A3Q26858784-A35761D9-7E21-49BC-AE1A-DA793A57AED4Q28475841-BEBB9023-3535-40A3-B2D9-2FD8050E05C2Q28487931-C3EDBB1A-CD75-4750-88A9-4645A0BF376AQ33499060-814274F5-B410-4A1D-8DE6-63EA711BA452Q34025773-B4133B37-0049-4052-B59C-98B26914D043Q34564423-C640B9E6-C923-4F83-A1EB-3E4189F93326Q35162384-98B7D519-8BE0-419B-8CB3-4B969599C18FQ36047920-D404C90D-8BD9-438F-B29E-4FC1970CDD37Q36589126-9EF01448-1A4E-4FC3-9A92-9067FD2F2738Q36719376-582B19C8-5F9A-4263-8857-F586BE206255Q36901340-FE3B357B-B957-4160-922D-02EA8D1715E2Q37950989-16973136-7C38-4732-90F4-1B567EF05610Q38977470-56316695-D24A-40C1-8984-A48083226FB2Q39453693-BB2A2426-2E59-4021-AD00-67A5C2C1B6B1Q39688462-0873C1AE-FA9B-4B3D-B6D2-D6057F9727E4Q40286964-1E1C8F1C-079F-4FE3-82F7-E7CD4EDACC5CQ46925767-799B3912-AE93-4730-842F-1699BA9E6AF2Q47723274-6AE67728-4C5D-4A43-A496-0B29450E0B24Q50133431-9581813D-BB02-416A-B30F-719606254132Q52604643-2F122764-FA94-4DCA-8FEA-63D2862E44BDQ53048761-D47D0A36-96C8-4738-98CA-8DAAAD2B2D24
P2860
How conducting a clinical trial affects physicians' guideline adherence and drug preferences.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
How conducting a clinical tria ...... dherence and drug preferences.
@ast
How conducting a clinical tria ...... dherence and drug preferences.
@en
How conducting a clinical tria ...... dherence and drug preferences.
@nl
type
label
How conducting a clinical tria ...... dherence and drug preferences.
@ast
How conducting a clinical tria ...... dherence and drug preferences.
@en
How conducting a clinical tria ...... dherence and drug preferences.
@nl
prefLabel
How conducting a clinical tria ...... dherence and drug preferences.
@ast
How conducting a clinical tria ...... dherence and drug preferences.
@en
How conducting a clinical tria ...... dherence and drug preferences.
@nl
P356
P1476
How conducting a clinical tria ...... adherence and drug preferences
@en
P2093
Jakob Kragstrup
Morten Andersen
P304
P356
10.1001/JAMA.295.23.2759
P407
P577
2006-06-01T00:00:00Z